Novel, neuroprotective uses of Copaxone (generic name: glatiramer acetate—GA) are being
examined, primarily in neurological conditions involving cognitive decline. GA is a well …

Background Chronic fatigue is a significant symptom in several diseases including traumatic
and degenerative neurological disorders. While several studies have investigated the …

Fatigue, attentional deficits and cognitive fluctuations are the most characterizing symptoms
of neurological involvement in Post COVID-19 syndrome (PCS). As the intraindividual …

Objective: Observational studies on aging and Alzheimer's disease (AD) typically focus on
mean-level changes in cognitive performance over relatively long periods of time (years or …

Objective: Persons with multiple sclerosis (PwMS) are at increased risk for cognitive
dysfunction. Considering the impact and potential ramifications of cognitive dysfunction, it is …

Increased variability in cognitive scores, mood or personality traits can be indicative of
underlying neurological disorders. Whether variability in cognition is due to changes in …

Background Self-and informant-report measures are often useful in predicting objective
cognitive performance; however, the relationship between these reports and mood, anxiety …

Objective Research on the neurocognitive effects of comorbid mood/anxiety disturbance in
college athletes is limited. Previous research found that athletes with comorbid …

Can digital technologies provide a passive unobtrusive means to observe and study
cognition outside of the laboratory? Previously, cognitive assessments and monitoring were …

Introduction: Cognitive impairment is a debilitating symptom in people with multiple sclerosis
(MS). Most of the neuropsychological tasks have little resemblance to everyday life. There is …